Mendel Launches Hypercube AI-Tool for Analyzing Life Sciences and Healthcare Data
Mendel, a developer of clinical artificial intelligence technology, has unveiled Hypercube, a new AI-copilot tool designed to empower life sciences and healthcare enterprises with an intuitive and conversational approach to analyzing vast troves of patient data. Hypercube leverages a unique blend of language modeling and symbolic AI to aid in the analysis of complex patient data.
The current landscape of employing AI in healthcare heavily relies on machine learning techniques, such as neural networks and large language models (LLMs). However, these approaches often struggle with clinical nuances and are susceptible to unpredictable errors. Hypercube stands apart by offering a proprietary hybrid method that merges large language modeling with symbolic AI, enabling it to clinically reason and interpret data with precision. This hybrid approach allows even non-technical users to pose questions in plain English, while advanced users and data scientists can benefit from query visualization and programmatic access for in-depth analysis.
Studies have shown that Hypercube can better select patients from clinical trial cohorts when compared to other AI tools. It also has shown higher quality of data, lower processing times, and lower query costs when compared to other commonly used AI tools.
To aid in development and testing of the technology, Mendel has collaborated with oncologists at the University of Pennsylvania School of Medicine to evaluate Hypercube’s performance against other leading LLMs, including GPT-4 and Llama2-7b. Dr. Ezekiel Emanuel, Vice Provost for Global Initiatives at the University of Pennsylvania, noted, “AI and large language models have the potential to identify patients eligible for clinical trials. The problem is that we don’t know which LLMs perform best. The results here suggest that domain-specific models can surpass generic LLMs at a scalable cost. With further validation, Hypercube could revolutionize tasks like our clinical trial screening process and streamline patient data inquiries.”
Mendel’s Hypercube platform is now open for early adopters and is expected to be accessible to all users in the first quarter of 2024.